GBP1 enhances lung adenocarcinoma invasiveness by binding beta-tubulin, increasing cell motility, and enabling metastatic dissemination to distant organs like lymph nodes, bones, or brain, driven by its GTPase activity and plasma membrane localization [18]. Here, GBP1 is linked to lung adenocarcinoma.